PIRO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 12.059
EU - Europa 6.573
AS - Asia 6.093
SA - Sud America 1.215
AF - Africa 891
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.856
Nazione #
US - Stati Uniti d'America 11.674
SG - Singapore 3.114
RU - Federazione Russa 2.044
IT - Italia 1.763
CN - Cina 1.358
BR - Brasile 1.018
IE - Irlanda 899
VN - Vietnam 581
UA - Ucraina 575
CI - Costa d'Avorio 442
FR - Francia 337
IN - India 303
CA - Canada 299
GB - Regno Unito 183
KR - Corea 182
DE - Germania 179
SE - Svezia 161
NG - Nigeria 160
SN - Senegal 150
FI - Finlandia 81
TR - Turchia 75
AR - Argentina 71
BD - Bangladesh 66
HK - Hong Kong 65
PL - Polonia 63
JP - Giappone 61
NL - Olanda 60
MX - Messico 52
IQ - Iraq 46
ZA - Sudafrica 46
UZ - Uzbekistan 44
AT - Austria 37
EC - Ecuador 36
ES - Italia 30
PK - Pakistan 30
CH - Svizzera 26
CO - Colombia 24
LT - Lituania 21
MA - Marocco 21
IR - Iran 20
LB - Libano 20
ID - Indonesia 19
GR - Grecia 18
KE - Kenya 18
AU - Australia 17
BJ - Benin 17
CL - Cile 17
VE - Venezuela 17
SA - Arabia Saudita 15
PY - Paraguay 13
BG - Bulgaria 11
AZ - Azerbaigian 10
BE - Belgio 10
CZ - Repubblica Ceca 10
EG - Egitto 10
AL - Albania 9
PH - Filippine 9
TN - Tunisia 9
NP - Nepal 8
PA - Panama 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
HR - Croazia 7
JO - Giordania 7
ET - Etiopia 6
EU - Europa 6
KZ - Kazakistan 6
RO - Romania 6
RS - Serbia 6
TH - Thailandia 6
HU - Ungheria 5
IL - Israele 5
MY - Malesia 5
OM - Oman 5
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KW - Kuwait 4
MK - Macedonia 4
PS - Palestinian Territory 4
SI - Slovenia 4
DK - Danimarca 3
DZ - Algeria 3
GD - Grenada 3
GE - Georgia 3
JM - Giamaica 3
LV - Lettonia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BY - Bielorussia 2
CR - Costa Rica 2
HN - Honduras 2
IS - Islanda 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
NZ - Nuova Zelanda 2
Totale 26.824
Città #
Dallas 2.070
Singapore 1.878
Santa Clara 1.311
Chandler 1.014
Dublin 897
Moscow 842
San Jose 719
Jacksonville 624
Ashburn 579
Chicago 446
Abidjan 442
Boardman 359
Catania 308
Lauterbourg 246
Cambridge 242
Lawrence 241
Andover 240
Hefei 222
Beijing 221
Los Angeles 218
Nanjing 208
Civitanova Marche 201
Kochi 189
Toronto 183
Seoul 181
Ho Chi Minh City 180
Wilmington 155
Dakar 150
Milan 148
Rome 143
Des Moines 132
Council Bluffs 129
Hanoi 127
New York 110
São Paulo 94
San Mateo 91
Abuja 81
Buffalo 81
Houston 80
Padova 64
Dong Ket 63
The Dalles 62
Lagos 61
Nanchang 61
Shenyang 59
Tokyo 58
Hong Kong 55
Bremen 54
Palermo 53
Hebei 51
Orem 50
Warsaw 50
Columbus 48
Lappeenranta 43
Montreal 43
Ottawa 43
Saint Petersburg 43
Munich 39
Jiaxing 38
Denver 36
Changsha 35
Chennai 34
Seattle 34
Stockholm 34
Brooklyn 32
Johannesburg 32
Phoenix 32
San Francisco 32
Belo Horizonte 31
Poplar 31
London 30
Rio de Janeiro 30
Amsterdam 28
Da Nang 27
Atlanta 26
Frankfurt am Main 25
Helsinki 25
Messina 25
Boston 24
Istanbul 24
Carrara 23
Tianjin 23
Tashkent 22
Rosolini 21
Boydton 19
Dhaka 18
Manchester 18
Mumbai 18
Port Harcourt 18
Washington 18
Brasília 17
Cotonou 17
Naples 17
Redondo Beach 17
Ankara 16
Baghdad 16
Mexico City 16
Nairobi 16
Pune 16
Charlotte 14
Totale 17.807
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 715
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 385
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 261
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 220
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 194
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 188
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 181
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 172
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 165
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 164
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 164
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 161
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 161
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 158
Antibiotic use and associated factors in a large sample of hospitalised older people 158
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 154
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 151
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 150
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 150
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 150
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 149
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 148
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 147
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 147
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? 146
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 146
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 146
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 145
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 144
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 143
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 141
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 141
Clinical and molecular biomarkers for diagnosis and staging of nafld 141
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 141
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 140
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 140
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 139
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 138
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 138
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 138
Candidate genes of SARS-CoV-2 gender susceptibility 138
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 137
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 137
Heart failure and chronic kidney disease in a registry of internal medicine wards 137
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 136
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 136
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 136
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 135
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 132
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 131
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 131
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 129
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 129
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 128
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 128
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 128
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 126
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 125
A molecular Systems Medicine approach to Diabetes Mellitus pinpoints the molecular bases of the higher resistance to cytokine-induced apoptosis of mammalian pancreas α cells respect to β cells 124
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 124
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 123
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 122
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 121
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 121
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 120
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 120
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 119
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 118
LONG NON-CODING RNA ASSOCIATI AL DIABETE MELLITO. FOCUS SULLE COMPLICANZE MICRO E MACROVASCOLARI 117
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 117
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 115
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 115
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 115
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 115
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 115
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 115
Acute diabetes complications 114
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 113
Alterazioni molecolari del segnale insulinico e del metabolismo degli FFA in pazienti con NASH 113
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 113
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women 113
Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta cells 112
Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs 111
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 110
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 109
Deregolazione del miRNoma intracellulare ed extracellulare ed analisi bioinformatica in modelli in vitro di NAFLD e NASH 109
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 109
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 109
MiR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 108
Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor-gamma Inhibition 107
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 104
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 103
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 103
Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP to ADP ratio 103
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 103
CEBPA exerts a specific and biologically important proapoptotic role in pancreatic β cells through its downstream network targets 103
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications 102
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease 102
Editorial on the Special Issue: "Pancreatic Islets of Langerhans: Not Only Beta-Cells" 102
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 102
Totale 14.152
Categoria #
all - tutte 87.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 0 0 0 0 0 152 103
2021/20221.824 185 252 9 36 308 55 267 69 141 9 59 434
2022/20233.044 257 156 46 310 275 501 10 591 709 18 108 63
2023/20241.449 67 232 73 70 68 309 48 133 17 38 223 171
2024/20256.495 696 850 324 418 1.167 639 242 217 369 535 634 404
2025/202611.625 698 516 2.330 827 1.823 2.306 1.479 282 659 696 9 0
Totale 27.316